Cancer immunograms could evaluate and visualize the cancer-immunity cycle status for each patient by eight IGSs: IGS1, T cell immunity; IGS2, tumor neoantigen burden (TNB); IGS3, priming and activation; IGS4, trafficking and infiltration; IGS5, recognition of tumor cells; IGS6, inhibitor cells; IGS7, checkpoint expression; and IGS8, inhibitor molecules [11]. Here, AMN is linked to cancer.